Antonio Arrieta

5.8k total citations · 2 hit papers
110 papers, 3.6k citations indexed

About

Antonio Arrieta is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Antonio Arrieta has authored 110 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Infectious Diseases, 51 papers in Epidemiology and 32 papers in Pharmacology. Recurrent topics in Antonio Arrieta's work include Antifungal resistance and susceptibility (30 papers), Antibiotics Pharmacokinetics and Efficacy (29 papers) and Pneumonia and Respiratory Infections (18 papers). Antonio Arrieta is often cited by papers focused on Antifungal resistance and susceptibility (30 papers), Antibiotics Pharmacokinetics and Efficacy (29 papers) and Pneumonia and Respiratory Infections (18 papers). Antonio Arrieta collaborates with scholars based in United States, United Kingdom and Canada. Antonio Arrieta's co-authors include Thomas J. Walsh, Jasjit Singh, Mary H. White, John R. Wingard, John Raffalli, E. Anaissie, Joseph Goodman, John S. Bradley, William Hope and Donald N. Buell and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and PEDIATRICS.

In The Last Decade

Antonio Arrieta

105 papers receiving 3.4k citations

Hit Papers

2018 Infectious Diseases Society of America Clinical Prac... 2018 2026 2020 2023 2018 2021 50 100 150 200

Peers

Antonio Arrieta
Irja Lutsar Estonia
Gary J. Noel United States
Linda M. Mundy United States
Urs B. Schaad Switzerland
Irja Lutsar Estonia
Antonio Arrieta
Citations per year, relative to Antonio Arrieta Antonio Arrieta (= 1×) peers Irja Lutsar

Countries citing papers authored by Antonio Arrieta

Since Specialization
Citations

This map shows the geographic impact of Antonio Arrieta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Arrieta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Arrieta more than expected).

Fields of papers citing papers by Antonio Arrieta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Arrieta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Arrieta. The network helps show where Antonio Arrieta may publish in the future.

Co-authorship network of co-authors of Antonio Arrieta

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Arrieta. A scholar is included among the top collaborators of Antonio Arrieta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Arrieta. Antonio Arrieta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arrieta, Antonio, Lindsay R. Grant, Bradford D. Gessner, et al.. (2025). Parapneumonic Empyema Complicating Community-acquired Pneumonia: Etiology in the Era of Pneumococcal Vaccination and Role of Molecular Diagnosis. The Pediatric Infectious Disease Journal. 44(7). 622–629.
2.
Young, Jo‐Anne H., David R. Andes, Monica I. Ardura, et al.. (2024). Modeling Invasive Aspergillosis Risk for the Application of Prophylaxis Strategies. Open Forum Infectious Diseases. 11(3). ofae082–ofae082. 12 indexed citations
3.
Segers, Heidi, Jaime G. Deville, William J. Muller, et al.. (2024). Safety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trial. Antimicrobial Agents and Chemotherapy. 68(12). e0048424–e0048424. 7 indexed citations
4.
Arrieta, Antonio, et al.. (2023). Invasive Mold Infections in Children: Navigating Troubled Waters with a Broken Compass. Infectious Diseases and Therapy. 12(6). 1465–1485. 1 indexed citations
5.
Arrieta, Antonio, Tricia Morphew, Karen L. Imfeld, et al.. (2023). Use of COVID-19 Convalescent Plasma for Treatment of Symptomatic SARS-CoV-2 Infection at a Children’s Hospital: A Contribution to a Still Inadequate Body of Evidence. Children. 10(2). 350–350. 1 indexed citations
6.
Bokesch, Paula M., Antonio Arrieta, John S. Bradley, Randall Hoover, & Sandra P. McCurdy. (2023). 1676. PK, Safety and Tolerability of VABOMERE® (meropenem-vaborbactam) in Infants, Children and Adolescents. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
7.
Ahmed, Mansoor M., Kathryn Akong, Jay H. Ryu, et al.. (2023). 590 Changing face of pediatric pulmonary exacerbations in cystic fibrosis. Journal of Cystic Fibrosis. 22. S313–S313. 1 indexed citations
8.
Adler‐Shohet, Felice C., et al.. (2017). Clofazimine for Treatment of Mycobacterium abscessus Infections in Children. Open Forum Infectious Diseases. 4(suppl_1). S675–S675. 2 indexed citations
9.
Cohen‐Wolkowiez, Michael, Barry T. Bloom, Antonio Arrieta, et al.. (2013). Determining Population and Developmental Pharmacokinetics of Metronidazole Using Plasma and Dried Blood Spot Samples From Premature Infants. The Pediatric Infectious Disease Journal. 32(9). 956–961. 36 indexed citations
11.
Avery, Robin K., Francisco M. Marty, Lynne Strasfeld, et al.. (2010). Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients. Transplant Infectious Disease. 12(6). 489–496. 93 indexed citations
12.
Freire, Antonio, Antonio Arrieta, & Nasrullah Undre. (2008). PHARMACOKINETICS OF MICAFUNGIN IN PEDIATRIC PATIENTS WITH INVASIVE CANDIDIASIS AND CANDIDEMIA. Archives of Disease in Childhood. 93. 1 indexed citations
13.
Yellin, Albert E., Jeffrey P. Johnson, Blaise L. Congeni, et al.. (2007). Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients. The American Journal of Surgery. 194(3). 367–374. 19 indexed citations
14.
15.
Singh, Jasjit, Antonio Arrieta, & David J. Lang. (2003). Neonate with chronic meningitis and hydrocephalus. The Pediatric Infectious Disease Journal. 22(11). 1025–1026. 2 indexed citations
16.
Bradley, John S., Carolyn E. Behrendt, Antonio Arrieta, et al.. (2001). Convalescent phase outpatient parenteral antiinfective therapy for children with complicated appendicitis. The Pediatric Infectious Disease Journal. 20(1). 19–24. 22 indexed citations
17.
Singh, Jasjit, et al.. (2001). Commonly Used Antibacterial and Antifungal Agents for Hospitalised Paediatric Patients. Pediatric Drugs. 3(10). 733–761. 13 indexed citations
18.
Arrieta, Antonio. (1997). Use of Meropenem in the Treatment of Serious Infections in Children: Review of the Current Literature. Clinical Infectious Diseases. 24(Supplement 2). S207–S212. 17 indexed citations
19.
Vugia, Duc J., Carol Peterson, Hildy Meyers, et al.. (1996). Invasive group A streptococcal infections in children with varicella in Southern California. The Pediatric Infectious Disease Journal. 15(2). 146–150. 63 indexed citations
20.
Merino, Fernando, et al.. (1986). ANTIBODIES TO AIDS-ASSOCIATED RETROVIRUS (HTLV-III/LAV) IN DRUG ADDICTS FROM VIZCAYA, NORTHERN SPAIN. PubMed. 2(2). 133–140. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026